Blood Stem Cell Transplant Failure
Showing 1 - 25 of >10,000
Blood Stem Cell Transplant Failure, Oral Mucositis, Nurse's Role Trial in Isparta (Oral mukositis nurse's education for
Completed
- Blood Stem Cell Transplant Failure
- +2 more
- Oral mukositis nurse's education for patients
-
Isparta, TurkeySüleyman Demirel Üniversitesi
Jan 27, 2023
Tacrolimus Blood Concentration and Transplant-related Outcomes
Recruiting
- Graft Vs Host Disease
- +2 more
- TAC C/D ratio
-
Trieste, ItalyIRCCS Burlo Garofolo
Oct 6, 2023
Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Kidney Failure, Kidney Transplant; Complications, Chimera Trial (other, procedure, drug)
Not yet recruiting
- Kidney Failure
- +2 more
- Bone Marrow Transplant
- +2 more
- (no location specified)
Jun 9, 2023
GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)
Recruiting
- GVHD
- +15 more
- FLUDARABINE
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United
Recruiting
- Bone Marrow Failure Syndrome
- +6 more
- Treosulfan
- +7 more
-
Los Angeles, California
- +23 more
Aug 15, 2022
Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)
Not yet recruiting
- Blood Disease
- TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
- CliniMACS® System
- (no location specified)
Jan 30, 2023
Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)
Active, not recruiting
- Chronic Granulomatous Disease Transplant
- Alemtuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)
Not yet recruiting
- Acute Leukemia
- Rifaximin with allogeneic stem cell transplant
- Allogeneic stem cell transplant
- (no location specified)
Sep 21, 2023
Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Recombinant Interleukin-7
-
Houston, TexasM D Anderson Cancer Center
Jan 26, 2023
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection Trial in Los Angeles (Donor CD34+,
Not yet recruiting
- End Stage Kidney Disease
- +3 more
- Donor CD34+, CD3+. and belumosudil
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Apr 6, 2023
Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,
Recruiting
- Stem Cell Transplant Complications
- +4 more
- Radiation
- +7 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Anemia, Sickle Cell Trial in New York (Siplizumab, Exchange Transfusion, Total Body Irradiation)
Recruiting
- Anemia, Sickle Cell
- Siplizumab
- +7 more
-
New York, New YorkColumbia University Irving Medical Center
Oct 9, 2023
Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)
Not yet recruiting
- Acute Myeloid Leukemia
- +6 more
-
Boston, Massachusetts
- +1 more
Mar 31, 2023
Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)
Active, not recruiting
- Plasma Cell Leukemia
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
GATA2, Immunodeficiency Trial run by the National Cancer Institute (NCI) (drug, radiation, procedure)
Not yet recruiting
- GATA2
- Immunodeficiency
- Mycophenolate Mofetil
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 23, 2023
Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)
Not yet recruiting
- Stem Cell Transplant Complications
- Eltrombopag 25 MG Oral Tablet
- Thrombopoietin
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 17, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,
Recruiting
- DOCK8 Deficiency
- Reduced-intensity hematopoietic stem cell
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,
Recruiting
- Sickle Cell Disease
- haploidentical stem cell transplant
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022
Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)
Not yet recruiting
- Graft Vs Host Disease
- +5 more
- CliniMACS® device
- (no location specified)
Jul 20, 2023
Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))
Not yet recruiting
- Transplantation, Hematopoietic Stem Cell
- Biological samples (blood and oral fluid)
-
Lyon, FranceHôpital de la Croix Rousse - service des maladies infectieuses e
Jul 7, 2023
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023